Abstract:Ethnopharmacological relevance: Gallic acid (GA) is a natural polyphenolic compound derived from Rhus chinensis Mill. with a variety of biological activities such as astringent sweat, cough, dysentery, hemostasis, and detoxification, and is widely used in China as a treatment for cough, bleeding, and gastrointestinal disorders. In recent years, the anticancer activity of GA has been demonstrated in a variety of cancers, affecting multiple cellular pathways associated with cancer onset, development and progression. Aim of the study: To investigate the role and potential mechanism of GA on gastric precancerous lesions (GPL), the key turning point of gastritis to gastric cancer, with the aim of delaying, blocking or reversing the dynamic overall process of "inflammation-cancer transformation" and thus blocking GPL to prevent the development of gastric cancer. Materials and methods: In this study, we established N-Nitroso-N-methylurea (MNU)-induced GPL mice model and induced precancerous lesions of gastric cancer cells (MC), i.e. epithelial mesenchymal transition (EMT), in human gastric mucosal epithelial cells (GES-1) with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). We used conventional pathology, immunohistochemistry, RNA sequencing, Western blot and other techniques to study the therapeutic effect of GA on GPL and its possiblemechanism in vitro and in vivo. Results: The results showed that compared with normal GES-1 cells, MC cells had the characteristics of malignant cells such as abnormal proliferation, invasion and metastasis, accompanied by decreased expression of EMT-related protein E-cadherin and increased expression of N-cadherin and Vimentin. GA can inhibit the malignant behavior of MC cell proliferation and induce its G0/G1 phase arrest, which is achieved by downregulating the Wnt/β-catenin signaling pathway and thereby inhibiting the EMT process. However, when we incubated with the Wnt pathway activator (Wnt agonist 1), the effect of GA was reversed. Furthermore, analysis of human gastric specimens showed that activation of the Wnt/β-catenin pathway was significantly associated with GPL pathological changes. Meanwhile, GA reversed MNU-induced intestinal metaplasia and partial dysplasia in GPL mice. Conclusion: Taken together, these results indicate that GA prevents the occurrence and development of GPL by inhibiting the Wnt/β-catenin signaling pathway and then inhibiting the EMT process, which may become potential candidates for the treatment of GPL.

Gallic Acid Inhibits Migration and Invasion of SCC-4 Human Oral Cancer Cells Through Actions of NF-κB, Ras and Matrix Metalloproteinase-2 and -9.

Gallic Acid Inhibits The Migration And Invasion Of A375.S2 Human Melanoma Cells Through The Inhibition Of Matrix Metalloproteinase-2 And Ras

Gallic Acid Inhibits Kaposi's Sarcoma‐associated Herpesvirus Lytic Reactivation by Suppressing RTA Transcriptional Activities

Gallic acid inhibits migration and invasion in human osteosarcoma U-2 OS cells through suppressing the matrix metalloproteinase-2/-9, protein kinase B (PKB) and PKC signaling pathways.

Gallic Acid Suppresses the Migration and Invasion of PC-3 Human Prostate Cancer Cells Via Inhibition of Matrix Metalloproteinase-2 and -9 Signaling Pathways.

Gallic Acid Induces DNA Damage and Inhibits DNA Repair-Associated Protein Expression in Human Oral Cancer SCC-4 Cells.

Influence of gallic acid in migration ability of human gastric carcinoma SGC-7901 cells

Ginkgolic Acid, a SUMO-1 Inhibitor, Inhibits the Progression of Oral Squamous Cell Carcinoma by Alleviating SUMOylation of SMAD4

Gallic acid induces apoptosis via caspase-3 and mitochondrion-dependent pathways in vitro and suppresses lung xenograft tumor growth in vivo.

Gallic acid as a cancer-selective agent induces apoptosis in pancreatic cancer cells.

Gallic Acid Induces Apoptosis in A375.S2 Human Melanoma Cells Through Caspase-Dependent and -Independent Pathways.

Geraniin inhibits oral cancer cell migration by suppressing matrix metalloproteinase‐2 activation through the FAK/Src and ERK pathways

Gallic Acid Inhibits Bladder Cancer T24 Cell Progression Through Mitochondrial Dysfunction and PI3K/Akt/NF-κB Signaling Suppression

Gallic Acid Hindered Lung Cancer Progression by Inducing Cell Cycle Arrest and Apoptosis in A549 Lung Cancer Cells via PI3K/Akt Pathway

Gallic Acid Induces the Apoptosis of Human Osteosarcoma Cells in Vitro and in Vivo Via the Regulation of Mitogen-Activated Protein Kinase Pathways

18Β-Glycyrrhetinic Acid Inhibits Migration and Invasion of Human Gastric Cancer Cells Via the ROS/PKC-α/ERK Pathway

Gallic acid alleviates gastric precancerous lesions through inhibition of epithelial mesenchymal transition via Wnt/β-catenin signaling pathway

Gambogic Acid Inhibits Invasion Of Osteosarcoma Via Upregulation Of Timp-1

Gallic acid attenuates LPS-induced inflammation in Caco-2 cells by suppressing the activation of the NF-κB/MAPK signaling pathway

Anti-Invasive Effect Of Gambogic Acid In Mda-Mb-231 Human Breast Carcinoma Cells

Antiproliferative Effect of Gallic Acid is Mediated via Mitochondrial‐ or ER‐Stress‐Induced Apoptosis and Canonical Autophagy in HT‐29 Cells